133 related articles for article (PubMed ID: 2187012)
1. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime.
Leung JW; Chan RC; Cheung SW; Sung JY; Chung SC; French GL
J Antimicrob Chemother; 1990 Mar; 25(3):399-406. PubMed ID: 2187012
[TBL] [Abstract][Full Text] [Related]
2. Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin.
Leung JW; Chan CY; Lai CW; Ko TC; Cheng AF; French GL
Antimicrob Agents Chemother; 1992 Sep; 36(9):2057-60. PubMed ID: 1416901
[TBL] [Abstract][Full Text] [Related]
3. The effect of biliary decompression on antibiotic biliary excretion.
Yamamoto S; Kubota Y; Takaoka M; Ogura M; Tsuji K; Yanagitani K; Shimatani M; Shibatani N; Imai Y; Takamidoh S; Inoue K
Hepatogastroenterology; 2002; 49(44):330-4. PubMed ID: 11995444
[TBL] [Abstract][Full Text] [Related]
4. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].
Hidaka K; Yamamoto H; Harada S; Katano M; Fujiwara H; Mizoguchi T; Hisatsugu T; Yamaoka K; Kisu T
Jpn J Antibiot; 1988 Sep; 41(9):1295-303. PubMed ID: 3241327
[TBL] [Abstract][Full Text] [Related]
5. [Clinical investigation of the biliary excretion of cefoperazone in obstructive jaundice].
Matsumoto T; Moriwaki M; Iizuka Y
Jpn J Antibiot; 1986 Oct; 39(10):2795-802. PubMed ID: 3806961
[TBL] [Abstract][Full Text] [Related]
6. Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers.
Lam YW; Duroux MH; Gambertoglio JG; Barriere SL; Guglielmo BJ
Antimicrob Agents Chemother; 1988 Mar; 32(3):298-302. PubMed ID: 3284457
[TBL] [Abstract][Full Text] [Related]
7. The effects of biliary obstruction on excretion of cefoperazone in the rat.
Fabre J; Rudhardt M; Dayer P; Trimble ER; Malè PJ
Arzneimittelforschung; 1984; 34(7):789-91. PubMed ID: 6541914
[TBL] [Abstract][Full Text] [Related]
8. Biliary excretion and pharmacokinetics of cefoperazone in humans.
Kemmerich B; Lode H; Borner K; Belmega D; Jendroschek T; Koeppe P; Goertz G
J Antimicrob Chemother; 1983 Jul; 12(1):27-37. PubMed ID: 6619045
[TBL] [Abstract][Full Text] [Related]
9. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
[TBL] [Abstract][Full Text] [Related]
10. [An experimental study on the biliary excretion of ceftizoxime in the presence and after relief of biliary obstruction with special reference to the influence of bile acid metabolism on the biliary excretion of the antibiotic].
Kawaguchi H
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):50-9. PubMed ID: 2733195
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cefoperazone: a review.
Craig WA; Gerber AU
Drugs; 1981; 22 Suppl 1():35-45. PubMed ID: 6456890
[TBL] [Abstract][Full Text] [Related]
12. Antibiotics, biliary sepsis, and bile duct stones.
Leung JW; Ling TK; Chan RC; Cheung SW; Lai CW; Sung JJ; Chung SC; Cheng AF
Gastrointest Endosc; 1994; 40(6):716-21. PubMed ID: 7859970
[TBL] [Abstract][Full Text] [Related]
13. Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.
Schwab D; Grauer M; Hahn EG; Mühldorfer S
Aliment Pharmacol Ther; 2005 Sep; 22(5):417-22. PubMed ID: 16128679
[TBL] [Abstract][Full Text] [Related]
14. The biliary excretion of sulphated and non-sulphated bile acids and bilirubin in patients with external bile drainage.
Dooley JS; Bartholomew C; Summerfield JA; Billing BH
Clin Sci (Lond); 1984 Jul; 67(1):61-8. PubMed ID: 6734078
[TBL] [Abstract][Full Text] [Related]
15. Increased biliary secretion of cysteinyl-leukotrienes in human bile duct obstruction.
Richter L; Hesselbarth N; Eitner K; Schubert K; Bosseckert H; Krell H
J Hepatol; 1996 Nov; 25(5):725-32. PubMed ID: 8938552
[TBL] [Abstract][Full Text] [Related]
16. Penetration of cefazolin, ceftriaxone, cefoperazone, and ceftazidime into human gallbladder tissue and bile.
Berger SA; Levy Y; Halevy A; Gorea A; Orda R
World J Surg; 1988 Oct; 12(5):641-4. PubMed ID: 3072775
[No Abstract] [Full Text] [Related]
17. [A pharmacokinetic study of cefoperazone during percutaneous transhepatic cholangial catheterization].
Suwa T; Toyama N; Hirakata S; Suzuki F; Oki A; Sato T; Miyoshi K; Sakimura K; Kurane R; Sakai H
Jpn J Antibiot; 1985 Aug; 38(8):2033-44. PubMed ID: 4078998
[TBL] [Abstract][Full Text] [Related]
18. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections].
Koizumi M; Simosegawa T; Yanbe M; Goto Y; Sugawara H; Kanno Y; Kanazawa Y; Kai Y; Sato T; Endou K
Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263
[TBL] [Abstract][Full Text] [Related]
19. Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan.
Saito A
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():255-62. PubMed ID: 6352628
[TBL] [Abstract][Full Text] [Related]
20. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.
Levi JU; Martinez OV; Malinin TI; Zeppa R; Livingstone A; Hutson D; Calhoun P
Antimicrob Agents Chemother; 1984 Dec; 26(6):944-6. PubMed ID: 6524908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
